Tian Di
State Key Laboratory Of Oncology In South China, P.R. China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Anti-angiogenic therapy combined with immune checkpoint blockade mediates CCR7 + CD8 + T-cell entry into HCC through high endothelial venules.
Journal: Hepatology (Baltimore, Md.)
Published: January 15, 2025
Long-Term Outcomes of Transarterial Chemoembolization plus Ablation versus Surgical Resection in Patients with Large BCLC Stage A/B HCC.
Journal: Academic radiology
Published: December 27, 2024
The novel BCL-2/BCL-XL inhibitor APG-1252-mediated cleavage of GSDME enhances the antitumor efficacy of HER2-targeted therapy in HER2-positive gastric cancer.
Journal: Acta pharmacologica Sinica
Published: June 21, 2024
APG-1252 combined with Cabozantinib inhibits hepatocellular carcinoma by suppressing MEK/ERK and CREB/Bcl-xl pathways.
Journal: International immunopharmacology
Published: May 07, 2024
A Prospective, Single-Arm, Phase 2 Study of Modified Transarterial Chemoembolization Using Low-Dose Chemotherapy with Blank Microspheres Plus Low-Dose Lenvatinib and Microwave Ablation in Patients with Large (≥7 cm) Unresectable Hepatocellular Carcinoma: The TALEM Trial.
Journal: Liver cancer
Published: August 17, 2023
A novel nomogram integrated with PDL1 and CEA to predict the prognosis of patients with gastric cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: October 08, 2022
High AKAP8L expression predicts poor prognosis in esophageal squamous cell carcinoma.
Journal: Cancer cell international
Published: November 29, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026